论文部分内容阅读
Introduction
Tumor lysis syndrome (TLS) is a potentially lethal emergency caused by lysed tumor cells, and it frequently occurs in tumors of hematologic origin. Up until now, there has been only one known report published overseas about TLS resulting from post-transplant lymphoproliferative disorder (PTLD)[1].